Can a seizure drug help kids with severe obesity?
NCT ID NCT02273804
First seen Jan 04, 2026 · Last updated Jun 14, 2026 · Updated 23 times
Summary
This study tested the drug topiramate in 18 severely obese children and teens aged 9-17. The goal was to see if it could lower body mass index (BMI) more than a placebo over 9 months. Participants had to have a very high BMI and had not succeeded with other weight-loss efforts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Bicêtre
Le Kremlin-Bicêtre, Paris, 94275, France
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.